Furthermore, in contrast to ficolin genes, the ovarian expression of MBL2 and MASP2 was significantly higher in ovarian sections from malignant tumours compared with benign tumours or normal tissue [25,26,28]. This evidence concerns the gene MASP2 and benign neoplasm.